The Effects of Hesperidin on Metabolic Syndrome

Not Applicable

• Conditions: Metabolic Syndrome
• Interventions: Dietary Supplement: hesperidin; Other: control

• Registration Number: NCT03734874
• Lead Sponsor: National Nutrition and Food Technology Institute

Brief Summary

To study the effects of Hesperidin supplement in patients with metabolic syndrome, 50 patients will be randomly allocated to control group or 2 capsules Hesperidin for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, metabolic factors will be assessed and compared between groups.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-01
• Study First Submitted: 2018-10-11
• Status Verified: 2018-11
• Primary Completion: 2018-11-01
• Study First Submitted QC: 2018-11-07
• Last Update Submitted: 2018-11-07
• Study First Posted: 2018-11-08
• Last Update Posted: 2018-11-08
• Study Completion: 2018-12-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Age of 18 to 70 years
• having 3 of 5 of high blood sugar, hypertension, high TG, high waist circumference, low HDL

Exclusion Criteria

• pregnancy or lactation
• A history of Cardiovascular disease, Pulmonary disease, Renal disease & Celiac disease; Cirrhosis
• Following program to lose weight in recent 3 mo

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
hesperidin	hesperidin	-
control	control	-

Primary Outcome Measures

Name	Time	Method
Metabolic syndrome: Number of participants with treated metabolic syndrome	12 weeks	number of participants with treated metabolic syndrome

Trial Locations

Locations (1)

National Nutrition and Food Technology Research Institute; 🇮🇷 Tehran, Iran, Islamic Republic of